Asgard Therapeutics
Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy
25 employees · est. 2018 · Lund, Sweden
Enara Bio
Advancing cancer immunotherapy by targeting the unconventional
66 employees · est. 2016 · Oxford, United Kingdom
Enara Bio is the older company (2018 vs 2016); Enara Bio is the larger of the two.
Side-by-Side Comparison
| Metric | Asgard Therapeutics | Enara Bio |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2016 older |
| Headquarters | ||
| Headquarters | Lund, Sweden | Oxford, United Kingdom |
| Employees | ||
| Employees | 25 | 66 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $36.00M | $50.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Not tracked yet | Development of cancer immunotherapies, Discovery of novel Dark Antigens, Optimization of bispecific T-cell engagers |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer patients, Biopharmaceutical companies, Medical research institutions |
| Taxonomy | ||
| Taxonomy | Biotech, Cancer Immunotherapy, Cell Reprogramming, Gene Therapy, Immune Responses, Antigen Presenting Cells, Personalized Medicine, Biological Technology, Oncology, Start-up, Investor-backed, Lund University, TrojanDC Technology, Novo Holdings, Boehringer Ingelheim Venture Fund | Cancer Immunotherapy, Dark Antigen Discovery, Solid Tumor Treatment, T-cell Engagers, EDAPT Platform, EnTiCE Platform, Genomic Dark Matter, Bispecific T-cell Engagers, Therapeutic Cancer Vaccines, Endogenous Retroviral DNA, Novel Cancer Targets, Biopharmaceuticals, Life Science Collaboration, Immunotherapy Development |
| Website | ||
| Website | asgardthx.com | enarabio.com |
About Asgard Therapeutics
Asgard Therapeutics, a Swedish biotech company founded in 2018, is at the forefront of cancer immunotherapy research through direct cell reprogramming technologies. The company's proprietary TrojanDC technology, originating from Lund University, aims to initiate immune responses by leveraging profes...
About Enara Bio
Enara Bio, founded in 2016 and headquartered in the United Kingdom, is carving a niche in the Biotechnology and Health Care sectors by focusing on unconventional cancer immunotherapy. With their slogan, "Advancing cancer immunotherapy by targeting the unconventional," the company aims to revolutioni...
We will tell you when either one moves
BounceWatch watches Asgard Therapeutics and Enara Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Asgard Therapeutics and Enara Bio — by email.
Frequently Asked Questions
Compare Asgard Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Asgard Therapeutics on 11 Sep 2024, and Enara Bio on 4 Feb 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.